CA2852537C - Permeant delivery system and methods for use thereof - Google Patents

Permeant delivery system and methods for use thereof Download PDF

Info

Publication number
CA2852537C
CA2852537C CA2852537A CA2852537A CA2852537C CA 2852537 C CA2852537 C CA 2852537C CA 2852537 A CA2852537 A CA 2852537A CA 2852537 A CA2852537 A CA 2852537A CA 2852537 C CA2852537 C CA 2852537C
Authority
CA
Canada
Prior art keywords
permeant
reservoir
delivery
approximately
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2852537A
Other languages
English (en)
French (fr)
Other versions
CA2852537A1 (en
Inventor
Jonathan Eppstein
David Enscore
Frank Tagliaferri
Gaurav Tolia
Shulun Chang
Alan Smith
Yogi Patel
Stuart Mcrae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Passport Technologies Inc
Original Assignee
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp filed Critical Nitto Denko Corp
Publication of CA2852537A1 publication Critical patent/CA2852537A1/en
Application granted granted Critical
Publication of CA2852537C publication Critical patent/CA2852537C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
  • Cosmetics (AREA)
CA2852537A 2005-06-17 2006-06-19 Permeant delivery system and methods for use thereof Expired - Lifetime CA2852537C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69189805P 2005-06-17 2005-06-17
US60/691,898 2005-06-17
CA2612511A CA2612511C (en) 2005-06-17 2006-06-19 Permeant delivery system and methods for use thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2612511A Division CA2612511C (en) 2005-06-17 2006-06-19 Permeant delivery system and methods for use thereof

Publications (2)

Publication Number Publication Date
CA2852537A1 CA2852537A1 (en) 2006-12-28
CA2852537C true CA2852537C (en) 2019-07-23

Family

ID=37571260

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2852537A Expired - Lifetime CA2852537C (en) 2005-06-17 2006-06-19 Permeant delivery system and methods for use thereof
CA2612511A Expired - Lifetime CA2612511C (en) 2005-06-17 2006-06-19 Permeant delivery system and methods for use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2612511A Expired - Lifetime CA2612511C (en) 2005-06-17 2006-06-19 Permeant delivery system and methods for use thereof

Country Status (14)

Country Link
US (1) US20070031495A1 (enExample)
EP (2) EP3311762B1 (enExample)
JP (3) JP5717316B2 (enExample)
CN (1) CN101262824B (enExample)
AU (1) AU2006261325B2 (enExample)
CA (2) CA2852537C (enExample)
ES (1) ES2667943T3 (enExample)
HK (1) HK1253408A1 (enExample)
IL (1) IL188145A0 (enExample)
IN (1) IN2015DN01758A (enExample)
MX (1) MX356649B (enExample)
SG (1) SG172736A1 (enExample)
TW (1) TWI419717B (enExample)
WO (1) WO2006138658A2 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003226605A1 (en) 2002-04-19 2003-11-03 Transpharma Medical Ltd. Handheld transdermal drug delivery and analyte extraction
US8016811B2 (en) * 2003-10-24 2011-09-13 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
CA2610757A1 (en) * 2005-06-10 2006-12-14 Transpharma Medical, Ltd. Patch for transdermal drug delivery
EP2029218B1 (en) 2006-06-15 2019-08-14 PolyPharma Pty Ltd A delivery system
CA2657435A1 (en) 2006-07-10 2008-07-03 Medipacs, Inc. Super elastic epoxy hydrogel
US8169122B1 (en) * 2006-12-15 2012-05-01 Dxna Llc Ultra sonic release of DNA or RNA
US7713196B2 (en) * 2007-03-09 2010-05-11 Nellcor Puritan Bennett Llc Method for evaluating skin hydration and fluid compartmentalization
JP5466161B2 (ja) * 2007-10-09 2014-04-09 トランスファーマ メディカル リミテッド 磁気的なパッチ連結物
CA2696227A1 (en) * 2007-10-17 2009-04-23 Transpharma Medical Ltd. Dissolution rate verification
EP2211918B1 (en) * 2007-10-29 2017-10-18 Syneron Medical Ltd. Vertical patch drying
US9995295B2 (en) 2007-12-03 2018-06-12 Medipacs, Inc. Fluid metering device
WO2009072108A2 (en) 2007-12-05 2009-06-11 Syneron Medical Ltd. A disposable electromagnetic energy applicator and method of using it
CN102088935B (zh) * 2008-03-31 2015-07-15 日东电工株式会社 透膜物递送系统
US8606366B2 (en) 2009-02-18 2013-12-10 Syneron Medical Ltd. Skin treatment apparatus for personal use and method for using same
WO2011032011A1 (en) 2009-09-10 2011-03-17 Medipacs, Inc. Low profile actuator and improved method of caregiver controlled administration of therapeutics
US20110172637A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including tissue support structure
US20110172639A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Device and method for delivery of microneedle to desired depth within the skin
US20110172609A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Microneedle component assembly for drug delivery device
US20110172645A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Wearable drug delivery device including integrated pumping and activation elements
US9500186B2 (en) 2010-02-01 2016-11-22 Medipacs, Inc. High surface area polymer actuator with gas mitigating components
KR101553742B1 (ko) * 2010-05-01 2015-09-16 가부시끼가이샤 옵토니쿠스 세이미쯔 경피 투여 장치 및 그 제조 방법
EP2601286A4 (en) 2010-08-02 2016-10-05 Brent L Weight UNDER PRESSURE CARTRIDGES FOR POLYMERASE CHAIN REACTIONS
US8668675B2 (en) 2010-11-03 2014-03-11 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
JP2015510956A (ja) 2012-03-14 2015-04-13 メディパックス インコーポレイテッド 過剰反応性分子を含むスマートポリマー材料
JP6243102B2 (ja) * 2012-05-01 2017-12-06 株式会社ジェムインターナショナル 貼付剤
WO2014179840A1 (en) * 2013-05-06 2014-11-13 Mupharma Pty Ltd Non-invasive agent applicator
CN112121302A (zh) 2014-05-06 2020-12-25 穆医药有限公司 非侵入性剂施用器
WO2016074040A2 (en) 2014-11-12 2016-05-19 Mupharma Pty Ltd Non-invasive agent applicator
EP3338853A1 (en) * 2016-12-23 2018-06-27 Sanofi-Aventis Deutschland GmbH Medicament delivery device
CN114269330B (zh) 2019-06-28 2025-07-22 帕斯帕特技术有限公司 透皮药物递送贴片、药物递送系统和药物递送方法
JP7522140B2 (ja) 2019-06-28 2024-07-24 パスポート テクノロジーズ、インコーポレイテッド フィラメント装置への熱送達を制御するための方法およびシステム
EP3989970B1 (en) 2019-06-28 2025-12-24 PassPort Technologies, Inc. Triptan microporation delivery system
EP3990099B1 (en) * 2019-06-28 2026-04-15 PassPort Technologies, Inc. Systems for delivering drugs through skin of a body
US20230001194A1 (en) * 2021-06-30 2023-01-05 Novocure Gmbh Methods and compositions for increasing circulation during treatment with alternating electric fields
US20250352494A1 (en) * 2022-06-10 2025-11-20 Passport Technologies, Inc. Transdermal delivery device for peptide delivery and methods of use
KR20260111605A (ko) * 2023-11-14 2026-07-15 린텍 가부시키가이샤 마이크로 니들 구조체 및 그 제조 방법

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1262564A (en) * 1983-09-01 1989-10-31 Minoru Sasaki Iontophoresis device
FR2562800A1 (fr) * 1984-04-11 1985-10-18 Fournier Laboratoires Dispositif pour l'administration percutanee de medicaments
US5032109A (en) * 1987-02-10 1991-07-16 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
JP3053913B2 (ja) * 1991-07-15 2000-06-19 帝三製薬株式会社 ビンポセチン類含有貼付剤
US5462743A (en) * 1992-10-30 1995-10-31 Medipro Sciences Limited Substance transfer system for topical application
US6377847B1 (en) * 1993-09-30 2002-04-23 Vyteris, Inc. Iontophoretic drug delivery device and reservoir and method of making same
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
GB2307414B (en) * 1995-08-29 1998-03-11 Spectrx Inc Microporation of human skin for drug delivery and monitoring applications
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
WO1998000193A1 (en) * 1996-07-03 1998-01-08 Altea Technologies, Inc. Multiple mechanical microporation of skin or mucosa
CN2274962Y (zh) * 1996-08-28 1998-02-25 林平 防渗透皮药贴
US6527716B1 (en) * 1997-12-30 2003-03-04 Altea Technologies, Inc. Microporation of tissue for delivery of bioactive agents
JP4182555B2 (ja) * 1997-11-21 2008-11-19 株式会社ポリトロニクス イオントフォレシス型の経皮投薬用素子
US6374136B1 (en) * 1997-12-22 2002-04-16 Alza Corporation Anhydrous drug reservoir for electrolytic transdermal delivery device
US6022316A (en) * 1998-03-06 2000-02-08 Spectrx, Inc. Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications
US6708060B1 (en) 1998-11-09 2004-03-16 Transpharma Ltd. Handheld apparatus and method for transdermal drug delivery and analyte extraction
US6148232A (en) * 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
US6597946B2 (en) * 1998-11-09 2003-07-22 Transpharma Ltd. Electronic card for transdermal drug delivery and analyte extraction
US20050191337A1 (en) * 1999-03-31 2005-09-01 L'oreal S.A. Patch with a magnetic field effect
US6611707B1 (en) * 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6692456B1 (en) * 1999-06-08 2004-02-17 Altea Therapeutics Corporation Apparatus for microporation of biological membranes using thin film tissue interface devices, and method therefor
US20030078499A1 (en) * 1999-08-12 2003-04-24 Eppstein Jonathan A. Microporation of tissue for delivery of bioactive agents
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US20020131994A1 (en) * 2001-01-10 2002-09-19 Schur Henry B. Non-irritating formulation for the transdermal delivery of substances
US6597794B2 (en) 2001-01-23 2003-07-22 Hewlett-Packard Development Company, L.P. Portable electronic device having an external speaker chamber
KR100904158B1 (ko) * 2001-03-16 2009-06-23 알자 코포레이션 펜타닐 투여용 경피성 패치
JP2002282371A (ja) * 2001-03-28 2002-10-02 Polytronics Ltd 低電圧駆動型イオントフォレシス素子
US7083580B2 (en) * 2001-04-06 2006-08-01 Mattioli Engineering Ltd. Method and apparatus for skin absorption enhancement and transdermal drug delivery
JP2003128536A (ja) * 2001-10-25 2003-05-08 Kenji Sugibayashi 温熱処理と併用する経皮吸収製剤
DE10159745A1 (de) * 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
WO2003077970A2 (en) * 2002-03-11 2003-09-25 Altea Therapeutics Corporation Transdermal integrated actuator device, methods of making and using same
US6945952B2 (en) * 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
IL152574A (en) * 2002-10-31 2009-09-22 Transpharma Medical Ltd A system for passing through the skin of dry items or dried medicines
JP2004202086A (ja) * 2002-12-26 2004-07-22 Teikoku Seiyaku Co Ltd エレクトロポレーション用薬物投与部、エレクトロポレーション用薬物投与システム、及びエレクトロポレーション用薬物投与方法
BRPI0409945A (pt) * 2003-04-30 2006-04-25 Purdue Pharma Lp forma de dosagem resistente à alteração
US8016811B2 (en) * 2003-10-24 2011-09-13 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
GB2414675B (en) * 2004-06-05 2006-09-06 Dewan Fazlul Hoque Chowdhury Transdermal drug delivery device
WO2006015299A2 (en) * 2004-07-30 2006-02-09 Microchips, Inc. Multi-reservoir device for transdermal drug delivery and sensing

Also Published As

Publication number Publication date
CA2612511C (en) 2014-08-12
WO2006138658A2 (en) 2006-12-28
JP2017113579A (ja) 2017-06-29
EP1906846A4 (en) 2012-12-19
CN101262824B (zh) 2011-06-29
IL188145A0 (en) 2008-03-20
CA2612511A1 (en) 2006-12-28
EP3311762A1 (en) 2018-04-25
TW200714300A (en) 2007-04-16
CN101262824A (zh) 2008-09-10
CA2852537A1 (en) 2006-12-28
EP3311762B1 (en) 2020-07-22
HK1253408A1 (en) 2019-06-14
ES2667943T3 (es) 2018-05-16
SG172736A1 (en) 2011-07-28
JP5717316B2 (ja) 2015-05-13
JP6692761B2 (ja) 2020-05-13
MX356649B (es) 2018-06-07
JP2008543872A (ja) 2008-12-04
TWI419717B (zh) 2013-12-21
WO2006138658A3 (en) 2007-03-01
US20070031495A1 (en) 2007-02-08
AU2006261325A1 (en) 2006-12-28
EP1906846A2 (en) 2008-04-09
JP6165184B2 (ja) 2017-07-19
EP1906846B1 (en) 2018-03-21
AU2006261325B2 (en) 2013-01-10
JP2015128599A (ja) 2015-07-16
IN2015DN01758A (enExample) 2015-05-29

Similar Documents

Publication Publication Date Title
EP3311762B1 (en) Permeant delivery system and methods for use thereof
CA3138128C (en) Permeant delivery system and methods for use thereof
US7335377B2 (en) Transdermal delivery system for dried particulate or lyophilized medications
AU2016231468B2 (en) Permeant delivery system and methods for use thereof
AU2013200313A1 (en) Permeant delivery system and methods for use thereof
HK1261888A1 (en) Permeant delivery system and methods for use thereof
HK1152637A (en) Permeant delivery system and methods for use thereof
HK1152637B (en) Permeant delivery system and methods for use thereof

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20141128

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251029

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20260212

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260212